NBRV - Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q4 2021 Results - Earnings Call Transcript

Nabriva Therapeutics plc (NBRV) Q4 2021 Results Earnings Conference Call March 29, 2022, 04:30 PM ET Company Participants Dan Dolan - Chief Financial Officer Ted Schroeder - Chief Executive Officer Steve Gelone - President and Chief Operating Officer Conference Call Participants Carl Byrnes - Northland Capital Presentation Operator Good day, and welcome to the Nabriva Therapeutics Fourth Quarter 2021 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] As a reminder, this call may be recorded. I would like to turn the call over to Dan Dolan, Nabriva's Chief Financial Officer. You may begin. Dan Dolan Thank you. And good afternoon, everyone. Welcome to the Nabriva's conference call and webcast where we will be discussing the fourth quarter 2021 earnings and providing a business update. The slides for today's presentation are

For further details see:

Nabriva Therapeutics plc (NBRV) CEO Ted Schroeder on Q4 2021 Results - Earnings Call Transcript